Sulfasalazine adverse effect — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Sulfasalazine-induced agranulocytosis
Explanation lettering: E = shown as A · C = shown as B · A = shown as C · B = shown as E
Sulfasalazine-induced agranulocytosis is best because early severe neutropenia with fever after sulfasalazine initiation indicates drug-induced agranulocytosis. A is less suitable because gout flare does not cause agranulocytosis; B is less suitable because hydroxychloroquine retinopathy causes visual changes after longer exposure; D is less suitable because reactive arthritis flare does not cause profound neutropenia; E is less suitable because methotrexate pneumonitis causes respiratory symptoms and diffuse lung change. Clinical pearl: early blood monitoring is particularly important after starting csDMARDs.
Reference: BSR csDMARD guideline 2025; BNF